Kimika Laboratories Spółka z Ograniczoną Odpowiedzialnością (KRS 0000499078, NIP 7393866041) is a Polish company, headquartered in Olsztyn, Warmińsko-Mazurskie voivodeship. KIMIKA LABORATORIES operates in: Other research and experimental development on natural sciences and engineering (PKD 72.19.Z). Industry: Research and development. The company has been listed in the National Court Register since March 5, 2014. KIMIKA LABORATORIES's most recently reported net revenue was 0 PLN for 2024.
Historical suspension of activities
Suspension: September 1, 2017 - resumed: May 21, 2025
No reported revenue
The company reported no revenue in any available reporting year. This may indicate a non-operating entity.
No arrears identified in the analyzed sources
No arrears or bankruptcy proceedings identified in the analyzed sources.
Business profile - Kimika Laboratories
Identity
- Name
- Kimika Laboratories Spółka z Ograniczoną Odpowiedzialnością
- Legal form
- SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
- Founded
- March 5, 2014
- Registry status as of
- April 23, 2026
- Latest entry
- April 23, 2026
- Founding act
- AKT NOTARIALNY Z DNIA 14.01.2014R., NOTARIUSZ EWA MALAK, KANCELARIA NOTARIALNA W OLSZTYNIE, REP. A NR 107/2014 AKTEM NOT…
Articles of association history (2)
- January 14, 2014: AKT NOTARIALNY Z DNIA 14.01.2014R., NOTARIUSZ EWA MALAK, KANCELARIA NOTARIALNA W OLSZTYNIE, REP. A NR 107/2014 AKTEM NOTARIALNYM Z DNIA 03.03.2014R., NOTARIUSZ EWA MALAK, KANCELARIA NOTARIALNA W OLSZTYNIE, REP. A NR 674/2014 ZMIENIONO: §13 UST.3 UMOWY SPÓŁKI.
- June 3, 2015: AKTEM NOTARIALNYM Z DNIA 03.06.2015R, REP. A NR 4124/2015, PRZED ZASTĘPCĄ NOTARIALNYM PAULINĄ TURLIK-RECZEK ZASTĘPUJĄCĄ NOTARIUSZA RADOSŁAWA KANIECKIEGO, KANCELARIA NOTARIALNA W ŁODZI : DO §4.1 DODANO PKT11, ZMIENIONO §5.1, §5.3, DO §5 DODANO UST.5 I UST.6; ZMIENIONO §10, §11.4, §11.8, §16, §22, SKREŚLONO §11.10, §12, §19.1, §20.1 PKT 16 I 17, ORAZ DOSTOSOWANO NUMERACJĘ PARAGRAFÓW.
Activities
Main activity
72.19.ZOther research and experimental development on natural sciences and engineering
General codes (divisions and groups)
General codes indicate a PKD division or group without a specific subclass.
Address and contact
- Address
- UL. WŁADYSŁAWA TRYLIŃSKIEGO, 12, 10-683, OLSZTYN, POLSKA
- Voivodeship
- WARMIŃSKO-MAZURSKIE
- District
- OLSZTYN
- KONTAKT@KIMIKA.PL
- Website
WWW.KIMIKA.PL- E-delivery address
- Not disclosed in the registry
- Coordinates
- 53.7817, 20.4742approx.
Risk and payment profile - Kimika Laboratories
Credibility rating
52.9 / 100
Average credibility
Insolvency risk
Very low
Low threat
Closure risk
14
/ 100
Risk comparison - scale 0 (safe) → 100 (critical)
Organizational stability signals
No instability signals - ownership, management, PKD codes and company name remain relatively stable.
Shareholder changes
1
1/12 yrs
Board changes
2
2/12 yrs
PKD changes
1
1/12 yrs
Name changes
0
0/12 yrs
Data from 12 years of registry activity.
Credibility history
Payment reliability score from 2019–2024
Current: D (53/100)
Trend: stable (0.0 pts/year)
Słaba wiarygodność płatnicza – wskaźniki finansowe sugerują podwyższone ryzyko opóźnień lub niewykonania zobowiązań.
Trade credit limit history
Standard limit from 2019–2024
Current: 0 PLN
Safe: 0 PLN
Difference between risk models
Closure - probability of ceasing operations (operational continuity). Insolvency - probability of formal bankruptcy / restructuring. The models use different data - results can diverge significantly when balance-sheet data is incomplete.
Operational status - Kimika Laboratories
Founded
March 5, 2014
12 years in operation
Legal form
SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
Registry: RejP
Headquarters
OLSZTYN
WARMIŃSKO-MAZURSKIE
Primary PKD
72.19.Z
Other research and experimental development on natural sciences and…
Share capital
15.1 K PLN
300 shares total
Shareholders
3
shareholders
Board
1 person
Filed years
6 years
2019–2024
Registry entries
33
latest: April 23, 2026
Revenue
0 PLN
2024
Net profit
0 PLN
2024
Assets
71.4 K PLN
2024
Equity
50.9 K PLN
2024
EBITDA
N/A
2024
no depreciation data
Valuation
53.6 K PLN
Low confidence
Low confidence
Companies in the same location
Public procurement
Trademarks
Reviews
Rate business credibility - Kimika Laboratories.
No ratings
Related articles
News
Bioceltix in the final EMA dialogue phase: BCX-CM-J could become Europe's first veterinary cell-therapy drug for dogs
Wrocław-based Bioceltix S.A. (KRS 0000744521) entered Q2 2026 in the final EMA dialogue phase regarding BCX-CM-J - Europe's first veterinary cell-therapy drug from mesenchymal stem cells for dogs with osteoarthritis. Responses to the final EMA questions are due in May 2026; the CVMP recommendation and marketing authorisation are possible in Q3/Q4 2026. Pre-commercial biotech: 2024 closed with a PLN 14.9 m loss on zero revenue; cash of PLN 33.6 m at year-end. Trigon DM maintained a buy rating with a price target of PLN 127.2.
News
Captor Therapeutics: PLN 36 m of cash at 30 September 2025, runway to mid-2026 - clinical data versus the cash clock
Wrocław-based Captor Therapeutics S.A. (KRS 0000756383) - a pre-commercial biotech specialising in TPD (Targeted Protein Degradation) - closed Q3 2025 with PLN 36 m of cash and grants securing financing to mid-2026. CT-01 (hepatocellular carcinoma) entered Phase I - the first patient dosed at Barcelona Clinic Liver Cancer. CT-03 (MCL-1 degrader) nearing clinical entry. Without a new R&D partnership or equity issuance in 2026, the company will need additional financing.
